BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 32697099)

  • 1. Hydrophilic and Electroneutral Nanoparticles to Overcome Mucus Trapping and Enhance Oral Delivery of Insulin.
    Tan X; Yin N; Liu Z; Sun R; Gou J; Yin T; Zhang Y; He H; Tang X
    Mol Pharm; 2020 Sep; 17(9):3177-3191. PubMed ID: 32697099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-penetrating peptide together with PEG-modified mesostructured silica nanoparticles promotes mucous permeation and oral delivery of therapeutic proteins and peptides.
    Tan X; Zhang Y; Wang Q; Ren T; Gou J; Guo W; Yin T; He H; Zhang Y; Tang X
    Biomater Sci; 2019 Jun; 7(7):2934-2950. PubMed ID: 31094367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium.
    Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H
    ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
    Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
    Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
    Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
    ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency.
    Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X
    Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of surface modification and size on oral drug delivery of mesoporous silica formulation.
    Wang Y; Cui Y; Zhao Y; Zhao Q; He B; Zhang Q; Wang S
    J Colloid Interface Sci; 2018 Mar; 513():736-747. PubMed ID: 29220688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs.
    Wu L; Liu M; Shan W; Zhu X; Li L; Zhang Z; Huang Y
    J Control Release; 2017 Sep; 262():273-283. PubMed ID: 28774842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models.
    Andreani T; Miziara L; Lorenzón EN; de Souza AL; Kiill CP; Fangueiro JF; Garcia ML; Gremião PD; Silva AM; Souto EB
    Eur J Pharm Biopharm; 2015 Jun; 93():118-26. PubMed ID: 25843239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
    Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y
    Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy.
    Niu Z; Samaridou E; Jaumain E; Coëne J; Ullio G; Shrestha N; Garcia J; Durán-Lobato M; Tovar S; Santander-Ortega MJ; Lozano MV; Arroyo-Jimenez MM; Ramos-Membrive R; Peñuelas I; Mabondzo A; Préat V; Teixidó M; Giralt E; Alonso MJ
    J Control Release; 2018 Apr; 276():125-139. PubMed ID: 29518466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted modulation of cell differentiation in distinct regions of the gastrointestinal tract via oral administration of differently PEG-PEI functionalized mesoporous silica nanoparticles.
    Desai D; Prabhakar N; Mamaeva V; Karaman DŞ; Lähdeniemi IA; Sahlgren C; Rosenholm JM; Toivola DM
    Int J Nanomedicine; 2016; 11():299-313. PubMed ID: 26855569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin.
    Liu X; Liu C; Zhang W; Xie C; Wei G; Lu W
    Int J Pharm; 2013 May; 448(1):159-67. PubMed ID: 23538098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
    Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
    Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactosamine-modified PEG-PLA/TPGS micelles for the oral delivery of curcumin.
    Sun S; Du X; Fu M; Khan AR; Ji J; Liu W; Zhai G
    Int J Pharm; 2021 Feb; 595():120227. PubMed ID: 33484915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming Multiple Absorption Barrier for Insulin Oral Delivery Using Multifunctional Nanoparticles Based on Chitosan Derivatives and Hyaluronic Acid.
    Chen Z; Han S; Yang X; Xu L; Qi H; Hao G; Cao J; Liang Y; Ma Q; Zhang G; Sun Y
    Int J Nanomedicine; 2020; 15():4877-4898. PubMed ID: 32753869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery.
    Wu J; Zheng Y; Liu M; Shan W; Zhang Z; Huang Y
    ACS Appl Mater Interfaces; 2018 Mar; 10(12):9916-9928. PubMed ID: 29504398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel nanoemulsion-based method to produce ultrasmall, water-dispersible nanoparticles from chitosan, surface modified with cell-penetrating peptide for oral delivery of proteins and peptides.
    Barbari GR; Dorkoosh FA; Amini M; Sharifzadeh M; Atyabi F; Balalaie S; Rafiee Tehrani N; Rafiee Tehrani M
    Int J Nanomedicine; 2017; 12():3471-3483. PubMed ID: 28496323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced oral absorption of insulin using colon-specific nanoparticles co-modified with amphiphilic chitosan derivatives and cell-penetrating peptides.
    Guo F; Ouyang T; Peng T; Zhang X; Xie B; Yang X; Liang D; Zhong H
    Biomater Sci; 2019 Mar; 7(4):1493-1506. PubMed ID: 30672923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
    Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
    Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.